Current Gene Therapy


Liang Cheng
College of Bioinformatics, Science and Technology
Harbin Medical University
Harbin, Heilongjiang

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 10 Issue: 5, October

Editorial [Hot topic: AAV-Mediated Gene Therapy for the Treatment of Retinal Diseases (Guest Editor: Fabienne Rolling)]

Volume:10   Issue: 5
Pp: 318-318
Fabienne Rolling
DOI: 10.2174/156652310793180733
Published on: 01 March, 2012

AAVs Anatomy: Roadmap for Optimizing Vectors for Translational Success

Volume:10   Issue: 5
Pp: 319-340
Angela M. Mitchell, Sarah C. Nicolson, Jayme K. Warischalk and R. Jude Samulski
DOI: 10.2174/156652310793180706
Published on: 01 March, 2012

Manufacturing and Regulatory Strategies for Clinical AAV2-hRPE65 open access plus

Volume:10   Issue: 5
Pp: 341-349
J. Fraser Wright, Jennifer Wellman and Katherine A. High
DOI: 10.2174/156652310793180715
Published on: 01 March, 2012

Retinal Blinding Disorders and Gene Therapy - Molecular and Clinical Aspects

Volume:10   Issue: 5
Pp: 350-370
Birgit Lorenz, Markus Preising and Knut Stieger
DOI: 10.2174/156652310793180698
Published on: 01 March, 2012

AAV-Mediated Gene Supply for Treatment of Degenerative and Neovascular Retinal Diseases

Volume:10   Issue: 5
Pp: 371-380
Pasqualina Colella and Alberto Auricchio
DOI: 10.2174/156652310793180670
Published on: 01 March, 2012

Gene-Based Therapies for Dominant Retinopathies

Volume:10   Issue: 5
Pp: 381-388
G. Jane Farrar, Arpad Palfi, Paul F.Kenna and Mary O'Reilly
DOI: 10.2174/156652310793180661
Published on: 01 March, 2012

Preclinical Studies on Specific Gene Therapy for Recessive Retinal Degenerative Diseases

Volume:10   Issue: 5
Pp: 389-403
Knut Stieger, Christine Chauveau and Fabienne Rolling
DOI: 10.2174/156652310793180689
Published on: 01 March, 2012

Major Challenges for Gene Therapy of Thalassemia and Sickle Cell Disease

Volume:10   Issue: 5
Pp: 404-412
Eleni Papanikolaou and Nicholas P. Anagnou
DOI: 10.2174/156652310793180724
Published on: 01 March, 2012